Literature DB >> 16127699

Development of Hsp25 expression compartments is not constrained by Purkinje cell defects in the Lurcher mouse mutant.

Carol L Armstrong1, M W Vogel, Richard Hawkes.   

Abstract

Four transverse zones can be distinguished in the adult mouse cerebellar cortex based on differential expression of cell-specific antigens, termination patterns of mossy fiber afferents, and phenotypes of mouse mutants with cerebellar defects: the anterior zone (AZ), central zone (CZ), posterior zone (PZ), and nodular zone (NZ). In the heterozygous Lurcher (Lc/+) mouse a zonally restricted abnormality in Purkinje cell development is seen. The Purkinje cell-specific antigen zebrin II is normally differentially expressed in all four zones of the adult cerebellum, but in the Lc/+ mutant is confined to the PZ and NZ, caudal to a transverse boundary in the dorsal aspect of lobule VIII. In this study we wanted to understand why zebrin II expression is arrested at this boundary and whether the Lc mutation affects the differentiation of additional Purkinje cell antigens in a similar manner. To determine this, we took advantage of the dynamic developmental timetable of another Purkinje cell antigen, the small heat shock protein Hsp25. Using immunohistochemistry we demonstrate that cerebellar maturation anterior to the CZ/PZ transverse boundary appears to be unaffected by the Lc allele, in that initial progression of Hsp25 expression in the Lc/+ cerebellum was similar to controls. Double-labeling experiments with anti-Hsp25 and anti-calbindin suggest that characteristic banding patterns of Hsp25 in Lc/+ cerebellum develop and are preserved despite cell loss. Thus, since simple temporal or spatial models cannot account for the zonal restriction seen during Lc/+ cerebellar development, the abnormality may be zebrin II-specific. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127699     DOI: 10.1002/cne.20703

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  7 in total

1.  Genetic subdivision of the tectum and cerebellum into functionally related regions based on differential sensitivity to engrailed proteins.

Authors:  Sema K Sgaier; Zhimin Lao; Melissa P Villanueva; Frada Berenshteyn; Daniel Stephen; Rowena K Turnbull; Alexandra L Joyner
Journal:  Development       Date:  2007-06       Impact factor: 6.868

Review 2.  Mechanisms of compartmental purkinje cell death and survival in the lurcher mutant mouse.

Authors:  Carol L Armstrong; Catherine A Duffin; Rebecca McFarland; Michael William Vogel
Journal:  Cerebellum       Date:  2011-09       Impact factor: 3.847

3.  Death and survival of heterozygous Lurcher Purkinje cells in vitro.

Authors:  Hadi S Zanjani; Rebecca McFarland; Pauline Cavelier; Andrei Blokhin; Vanessa Gautheron; Carole Levenes; Linda L Bambrick; Jean Mariani; Michael W Vogel
Journal:  Dev Neurobiol       Date:  2009-07       Impact factor: 3.964

4.  Engrailed homeobox genes determine the organization of Purkinje cell sagittal stripe gene expression in the adult cerebellum.

Authors:  Roy V Sillitoe; Daniel Stephen; Zhimin Lao; Alexandra L Joyner
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

5.  Cerebellar Expression of the Neurotrophin Receptor p75 in Naked-Ataxia Mutant Mouse.

Authors:  Maryam Rahimi Balaei; Xiaodan Jiao; Niloufar Ashtari; Pegah Afsharinezhad; Saeid Ghavami; Hassan Marzban
Journal:  Int J Mol Sci       Date:  2016-01-15       Impact factor: 5.923

6.  The Reelin receptors Apoer2 and Vldlr coordinate the patterning of Purkinje cell topography in the developing mouse cerebellum.

Authors:  Matt Larouche; Uwe Beffert; Joachim Herz; Richard Hawkes
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240

7.  Purkinje cell compartmentation in the cerebellum of the lysosomal Acid phosphatase 2 mutant mouse (nax - naked-ataxia mutant mouse).

Authors:  Karen Bailey; Maryam Rahimi Balaei; Ashraf Mannan; Marc R Del Bigio; Hassan Marzban
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.